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Abstract A total of 12 non-epidemiologically related
clinical isolates of Streptococcus mitis that showed dif-
ferent levels of resistance to penicillin were studied.
Membrane-protein proﬁles and penicillin-binding protein
(PBP) patterns showed a great polymorphism; and pat-
terns of 4–7 PBPs, with sizes that ranged from101 kDa
to40 kDa, were detected in each strain. No association
could be found between PBP pattern and resistance level
to penicillin among these isolates. Arbitrarily primed
PCR conﬁrmed the genetic diversity among this group of
streptococci. One of the isolates of intermediate level of
resistance to penicillin, which showed a PBP pattern
similar to that of the high-resistance strains, was used as a
laboratory model to analyse the mechanism underlying
high-resistance acquisition by these strains. A 14-fold in-
crease in penicillin resistance was obtained after a single
selection step, which resulted in a decrease in penicillin
aﬃnity for PBP1. The size of this PBP (92 kDa) and the
diﬀerences in PBP proﬁles of the penicillin-resistant clin-
ical isolates suggest the existence in S. mitis of PBP-me-
diated mechanisms to acquire high-level resistance to
penicillin, amongwhich alterations inPBP1 seem toplay a
main role, in contrast to the PBP2Xmediated mechanism
described for other streptococci.
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Introduction
Although viridans streptococci were generally consid-
ered uniformly susceptible to penicillin, strains show-
ing penicillin-resistance were reported in 1962 from
patients with gingival infection [20]. Today, the in-
crease in resistance of viridans streptococci to penicil-
lin [1] is a cause of concern in the treatment of
infectious endocarditis, infections in patients with
haematological malignancies receiving cytotoxic che-
motherapy and in neonatal infections [3, 4, 5, 6, 14,
15, 25].
Among the viridans streptococci, Streptococcus mitis
has been considered the species with the highest level
of resistance to penicillin [1]. Penicillin resistance in
clinical isolates of S. mitis seems to be due to the
production of altered high-molecular-mass penicillin-
binding proteins (PBPs) with a low binding aﬃnity for
penicillin [2, 11, 22]. These PBPs, encoded by chrom-
osomal genes, are located in the cytoplasmic mem-
brane and catalyse reactions in the ﬁnal steps of
bacterial peptidoglycan synthesis. The implication of S.
mitis in homologous recombination events that lead to
mosaic genes in pneumococci has been extensively
analysed [8, 9]. There are few reports, however, on
PBP proﬁles and genes of clinical isolates of S. mitis or
on their relationships with the levels of resistance to
penicillin [2].
In this report, we analyse PBPs and whole-protein
proﬁles of 12 non-epidemiologically related penicillin-
resistant clinical isolates of S. mitis to study the degree of
diversity among PBP patterns.
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Materials and methods
Bacterial strains
A total of 12 non-epidemiologically related penicillin-resistant
clinical isolates of S. mitis strains isolated from blood were
provided by the Department of Microbiology, Hospital Ramo´n y
Cajal (Madrid, Spain). Alpha-haemolytic streptococci were iden-
tiﬁed to species level, using the API 20 Strep system [10]. The
strains used in PBP studies displayed similar biochemical proﬁles.
All of the strains fermented raﬃnose and melibiose. None of the
strains fermented mannitol and inulin; and hydrolysis of esculin,
arginine and hippurate were negative. None of the strains produced
polysaccharides from sucrose. S. mitis ATCC 9811 was used as a
penicillin-susceptible reference strain and Escherichia coli BM-21
was used as control in the PBP proﬁle studies.
Antimicrobial agents
Penicillin, ampicillin, cephalothin, cefotaxime and imipenem were
provided by their respective manufacturers. [3H]-benzylpenicillin
(77.8 mCi/mg, 8.9 mCi/ml) was provided by Merck & Co.
(Rahway, USA).
Susceptibility testing
The minimum inhibitory concentrations (MIC) of penicillin and
other b-lactam antibiotics against S. mitis strains were determined
by microdilution technique, using cation-adjusted Mueller-Hinton
broth with 5% lysed horse blood, in accordance with the guidelines
of the National Committee for Clinical Laboratory Standards [21].
The inoculum was prepared by suspending several colonies from
overnight blood agar culture in sterile 0.9% saline, adjusted to a
turbidity equal to 0.5 McFarland standard. The suspension was
further diluted to provide a ﬁnal concentration of bacteria of
5·105 colony forming units (cfu) in each well of the microdilution
trays. The microtitre plates were incubated in air at 35 C for 20–
24 h. Strains were classiﬁed for penicillin susceptibility as follows:
susceptible at MIC £ 0.12 lg/ml, intermediately resistant at MIC
=0.25–2.00 lg/ml and highly resistant at MIC ‡ 0.4 lg/ml
[21]. S. mitis ATCC 9811 and S. pneumoniae ATCC 49619 were
used as quality control strains.
Isolation of a penicillin-resistant mutant
A spontaneous penicillin-resistant mutant was obtained by
spreading 109 cfu S. mitis 8168 over Todd-Hewitt (Oxoid, Unipath,
Basingstoke, UK) agar plates supplemented with 5% sheep blood
and a gradient of penicillin concentrations of 0–32 lg/ml. A colony
that could grow in the presence of 32 lg penicillin/ml was isolated.
The mutant was maintained on Todd-Hewitt agar plates supple-
mented with 5% sheep blood containing sub-inhibitory penicillin
concentrations.
Electrophoresis of soluble membrane proteins
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) was performed essentially as described by Laemmli [16].
The acrylamide concentration used for the gels was 8% for the
general analysis of membrane proﬁles and PBP patterns of diﬀerent
S. mitis isolates (Fig. 1) and 12% for the resolution of similar-sized
PBPs (Figs. 3, 4). The gels were stained with Coomassie brilliant
blue R0250.
Puriﬁcation of cell membrane
Plasma membranes from S. mitis were obtained using a modiﬁ-
cation of a described method [13, 29], suitable for b-lactam bind-
ing. Two lytic enzymes, mutanolysin (an endo-N-acetyl
muramidase from Streptomyces globisporius) and lysozyme were
combined in sequential and controlled steps. All Streptococcus
mitis strains were grown overnight at 37 C in Todd-Hewitt broth
supplemented with 5% yeast extract (Difco Laboratories, Detroit,
Mich.). Growth was monitored by measuring the optical density at
620 nm (OD620), to reach an OD620 of 0.4. Cells were centrifuged
at 12,500 g for 10 min and, after discarding the supernatant, they
were resuspended in 10 ml of 50 mM sodium phosphate buﬀer
(pH 6.7) and centrifuged again. The pellet was resuspended in
8.5 ml of an enzymatic solution containing 50 mM Tris-HCl
(pH 6.5), 1.2 mM magnesium chloride and 100 lg mutanolysin/ml
and incubated for 1 h at 37 C, with periodic shaking. The tubes
were transferred to an ice bath and 8 mg lysozyme/ml was added.
After shaking and incubation at 37 C for 20 min, the suspension
was disrupted by ultrasonic treatment using a Branson Sonic B-30
sonicator and then 2 ll of DNase and 4 ll of RNase were added.
Unbroken cells were discarded by centrifugation at 9,800 g for
5 min. Membranes were sedimented by centrifugation at 245,000 g
for 1 h, washed in 50 mM sodium phosphate buﬀer (pH 6.7) and
centrifuged three times at 39,200 g for 45 min. The last pellet was
resuspended in 50 mM sodium phosphate buﬀer (pH 6.7) at a ﬁnal
protein concentration of 5–6 mg/ml. All centrifugations were run
at 4 C; and the protein concentration was calculated by the
Bradford technique [3]. We obtained 0.625 mg membrane protein/l
original cell culture.
Labelling of PBPs with radioactive benzylpenicillin
and determination of the aﬃnities of PBPs for penicillin
Aliquots (50 ll) of a membrane suspension (0.3–0.4 mg of protein)
were incubated for 15 min at 37 C with 52 lg of [3H]-benzylpen-
icillin/ml. Binding was stopped by isotopic dilution with benzyl-
penicillin (ﬁnal concentration, 10 mg/ml) and samples were further
processed as described previously [26].
Isolation and sequencing of DNA
Genomic DNA for use in arbitrarily primed PCR (AP-PCR) [27]
and PCR techniques was obtained from isolated bacterial colonies,
using the method described by Flamm et al. [12] with modiﬁcations.
ITS-2 [28] and SM1 [19] primer sequences for AP-PCR, MS1 and
MS2 [17, 24] primers for sequencing of genes and PCR parameters
Fig. 1 Penicillin-binding protein (PBP) patterns of Streptococcus
mitis isolates with diﬀerent levels of penicillin resistance. Lanes 1, 2
Escherichia coli (molecular mass marker), lanes 3, 4 ATCC 9811
(susceptible), lanes 5, 6 1182 (intermediately resistant), lanes 7, 8
730 (resistant), lanes 9, 10, 8168 (intermediate), lanes 11, 12 72244
(resistant), lanes 13, 14 38259 (highly resistant). Lanes 2, 4, 6, 8, 10,
12, 14 are samples that were incubated for 10 min with 10 mg/ml
of non-radioactive penicillin before the labelling reaction. The
proteins were separated by SDS-PAGE (8% acrylamide) and
subjected to ﬂuorography
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for use in ampliﬁcation were those previously described [8, 17, 24].
Double-stranded DNA (PCR products) were sequenced by the
deoxynucleotide method of DNA sequencing of Sanger et al. [23].
When the PCR products were sequenced, a minimum of two in-
dependent PCR products were sequenced to eliminate any errors
introduced by PCR. Ampliﬁcation products were analysed by
electrophoresis (0.25 V/cm2) in 1.2% (w/v) agarose gels stained
with ethidium bromide.
Results and Discussion
MIC of the b-lactam antibiotics tested against the
S. mitis isolates are shown in Table 1. Cefotaxime and
imipenem presented the highest activity against all
penicillin-resistant strains, whereas ampicillin and
cephalothin showed slightly higher MICs than penicillin
against those strains. In general, penicillin-resistant
viridans streptococci also showed a decreased suscepti-
bility to all b-lactam agents tested.
The S. mitis strains used in the PBP studies (strains
ATCC 9811, 1182, 730, 8168, 72244, 38259) displayed
similar biochemical proﬁles, using the API 20 Strep
system. However, great polymorphisms in membrane
protein (data not shown) and PBP proﬁles were found.
Fig. 1 shows the PBP proﬁles of S. mitis strains with
diﬀerent resistance levels to penicillin. The PBPs of the
organisms exhibited a wide range of molecular weights.
The pattern of PBPs obtained by in vitro labelling of
resistant stains with [3H]-benzylpenicillin showed im-
portant diﬀerences with respect to that of the susceptible
strains. These include the number of PBPs, the aﬃnity
for [3H]-benzylpenicillin and the molecular weight pro-
ﬁles. Even those strains with the same penicillin MIC
showed these diﬀerences (data not shown). The multi-
plicity of changes observed in the PBPs of these strains
suggests that high-level resistance to penicillin does not
involve sequential alterations, as previously described by
Zighelboim and Tomasz for S. pneumoniae strains [30],
but are most probably the consequence of a much more
complex process, in which vertical and horizontal gene
transfers take place.
Due to the high heterogeneity found in the protein
proﬁles of the diﬀerent strains, it was diﬃcult to assess
the implication of a particular PBP in penicillin resis-
tance, as was proposed for the role of PBP2X in
S. pneumoniae [7, 18] and other species [9, 24]. More-
over, our data support that a PBP similar in size to the
PBP2X in pneumococci is not always detected among
the proﬁles of the strains tested (i.e. lane 7 of Fig. 1). If
alterations in PBP2X-like protein were not the main
mechanism to reach penicillin resistance, it should be
possible to check this hypothesis through the analysis of
highly penicillin-resistant spontaneous mutants of one
Table 1 Minimum inhibitory concentration (MIC) of b-lactam antibiotics against Streptococcus mitis strains
S. mitis strain MIC (lg/ml)
Penicillin Ampicillin Cephalothin Cefotaxime Imipenem
8168 2.0 8.0 8.0 2.0 1.0
1182 4.0 4.0 4.0 2.0 0.1
16785 4.0 8.0 16.0 0.5 0.1
16453 8.0 16.0 32.0 1.0 0.5
730 8.0 16.0 8.0 2.0 1.0
48427 16.0 16.0 16.0 4.0 1.0
34986 16.0 32.0 16.0 2.0 2.0
72244 16.0 32.0 32.0 4.0 2.0
60829 16.0 32.0 32.0 8.0 0.5
5693 16.0 32.0 >32.0 4.0 £ 0.01
68989 32.0 >32.0 >32.0 32.0 4.0
38259 32.0 16.0 16.0 2.0 0.03
ATCC 9811 £ 0.03 £ 0.06 £ 0.03 £ 0.06 £ 0.12
Fig. 2A–C Arbitrarily primed (AP)-PCR. A AP-PCR proﬁles from
S. mitis isolates with ITS-2 primer. Lane 1 ME-32, lane 2 38259
(highly resistant), lane 3 68989 (highly resistant), lane 4 8168
(parental strain), lane 5 ATCC 9811 (susceptible), lane 6 size
marker (100 bp). B AP-PCR proﬁles from S. mitis isolates with
SM1 primer. Lane 1 ME-32 (resistant mutant), lane 2 8168
(parental strain), lane3 ATCC 9811 (susceptible), lane 4 size
marker (100 bp), lane 5 38259 (highly resistant), lane 6 68989
(highly resistant). C PCR ampliﬁcation of chromosomal DNA
samples from S. mitis 8168 (lanes 2, 3) and the ME-32 mutant
(lanes 4, 5) with MS1 and MS2 primers. The lanes contained 10 ll
of a reaction mixture with sample diluted 1:10 (lanes 2, 4) or 1:100
(lanes 3, 5). Lane 1 contained 1 lg/ml of a molecular mass marker
(100 bp ladder)
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of the clinical strains with a low level of penicillin
resistance. In this sense, strain 8168 (lane 9) was selected
as the parent for selection, since it had a PBP pattern
similar to that of the highly resistant strain, 38259
(lane 13, MIC=32 lg/ml), but a lower MIC (2 lg/ml)
for penicillin. A resistant mutant named ME-32 was
obtained, for which the benzylpenicillin MIC was 64
lg/ml. Increases in the MIC of cefotaxime >8 lg/ml)
and imipenem (4 lg/ml) were also observed in the mu-
tant strain.
The ME-32 strain showed biochemical and mem-
brane-protein proﬁles identical to its parental strain
(data not shown). Moreover, AP-PCR of both strains
with primers ITS-2 and SM1 also gave identical proﬁles.
However, a comparison of these AP-PCR proﬁles to
those of other resistant clinical isolates revealed great
diﬀerences among them, supporting the existence of a
large genetic diversity among penicillin-resistant S. mitis
isolates (Fig. 2A, B).
Characterization by saturation studies of both
parental and mutant strains showed ﬁve PBPs with
approximate apparent sizes of 92, 88, 85, 79 and
43 kDa (PBP1–PBP5; Figs. 3A, 4A). The apparently
diﬀerent PBP patterns in Figs. 1, 3A and 4A are a
consequence of the diﬀerent gel concentrations used.
Analysis of PBPs in ME-32 and in its parental strain
indicated an association between resistance and
Fig. 3A, B Aﬃnity of S. mitis 8168 PBPs for [3H]-benzylpenicillin.
Increasing concentrations of [3H]-benzylpenicillin were incubated
for 10 min at 30 C with membrane aliquots isolated from
S. mitis 8168. After stopping the reaction with an excess of cold
penicillin, the proteins were separated by SDS-PAGE (12%
acrylamide) and subjected to ﬂuorography. A Fluorogram of the
experiment. Lane C Control for non-speciﬁc binding, lane E E. coli
membranes used as molecular mass marker of the sizes indicated at
the right. B Densitometric analysis of the experiment shown in A.
The ﬂuorogram from A was quantiﬁed by microdensitometry; and
the intensity of each band was plotted versus the concentration of
labelled benzylpenicillin
Fig. 4A, B Aﬃnity of S. mitis ME-32 (mutant strain) PBPs for
[3H]-benzylpenicillin. Membrane preparation aliquots isolated
from the S. mitis ME-32 were incubated with increasing concen-
trations of [3H]-benzylpenicillin as above; and the proteins were
separated by SDS-PAGE (12% acrylamide). A Fluorogram
showing the results of the labelling. B Densitometric analysis of
the results shown in A
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decreased aﬃnity of PBP1 for penicillin. No saturation
of PBP1 in the mutant strain was observed, even when
the antibiotic used was six-fold more labelled than that
in its parent (Figs. 3B, 4B). Thus, the increasing level
of resistance correlates with the decrease in aﬃnity of
the high-molecular-weight PBP1. These data are in
agreement with the recent work of Amoroso et al. [2],
in which they found a much lower binding of
[125I]-penicillin to all the high molecular mass PBPs in a
clinical isolate of S. mitis with high resistance to
b-lactams, and show in a laboratory model that a 16-
fold increase in the resistance level to penicillin can be
achieved by a change in PBP1 in a single selection step.
Furthermore, due to the high molecular weight of
the PBP1 of the ME-32 strain, it probably has no
genetic correspondence with the so-called PBP2X of
S. pneumoniae, previously reported [2] as the main
protein responsible for streptococci interspecies distri-
bution of the penicillin-resistant phenotype [8, 9, 24].
However, as in many membrane proteins, the mobility
of PBP1 in SDS-PAGE could not reﬂect their actual
molecular size, thus making a putative relationship
between them still possible. To check this, we ampliﬁed
and sequenced the gene encoding the PBP2X-like pro-
tein from the genomes of the ME-32 and its parental
strain. A 2.2-kbp product was ampliﬁed from each
strain, using MS1 and MS2 primers (Fig. 2C), and
subsequently sequenced (data not shown). The com-
parison of both sequences revealed a total identity
between them. In addition, the sequence obtained
encoded an amino acid sequence which corresponded
to the PBP2X from sensitive strains of S. pneumoniae
[7, 9, 17, 24] (data not shown). Consequently, the
penicillin resistance of our S. mitis ME-32 strain was
not due to a mutation in a PBP2X-like gene.
In conclusion, our data support that clinical isolates
of penicillin-resistant S. mitis present a high phenotypic
and genotypic heterogeneity and, the studies performed
on our resistant isolate suggest that at least a mutation
of a PBP gene diﬀerent from that of the well known
PBP2X could suﬃce to produce a high level of resistance.
Nevertheless, more penicillin-resistant S. mitis strains
need to be evaluated in order to support these results.
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